2024-03-28T16:36:41Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_C740C8A4B31F
2024-03-23T02:58:00Z
serval:BIB_C740C8A4B31F
Tumoranämie. Ubersicht über die Rolle des humanen rekombinanten Erythropoetins (r-hu-EPO) bei der Behandlung der Tumoranämie [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
10067375
Monnerat
C.
author
Leyvraz
S.
author
article
review
1999-01
Praxis
1661-8157
1661-8157
journal
88
5
178-188
Adult
Anemia/etiology
Anemia/therapy
Clinical Trials as Topic
Erythropoietin, Recombinant/adverse effects
Erythropoietin, Recombinant/therapeutic use
Humans
Neoplasms/complications
Neoplasms/therapy
Treatment Outcome
ger
60_published
Publication types: English Abstract ; Journal Article ; Review